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Rotavrruses are the leadlng cause of acute diarrhoea In infants and young 
children worldwide causing over a mrlllon deaths annually In developrng 
countries Rotavlrus, whose genome conslsts of 11 double-stranded RNA 
segments, belongs to the famrly Reowrldae Rotavlruses have been classiflgd 
into seven groups, A to G, based on group-speciflc antrgens detected primarily 
on the intermediate capsid protein, VP6 Group A rotawruses exh~brt two 
commonly studied serolog~c spec~frcrties I e l  subgroup and serotype and are 
subject to extensrve studies as they constitute the majority of rotawruses in man 
VP6, the rntermedrate capsid prote~n encoded by the 6th segment of wral RNA, is 
the subgroup-specific antrgen At least four distinct subgroup (SG) specrficrtres, 
I e , SGI, SGII, SGI/II and SG non (l/Il), have been identified among group A 
rotawruses The outer caps~d protelns VP4 and VP7 specify two independent 
serotype specrficrt~es, I e , the P type (for protease-sensltiwty of VP4) and G 
serotype (for glycoprotein nature of VP7), respectively In contrast to P serotype 
charactenzatton, rotmruses from both humans and animals have been well 
classified ~nto at least 14 G serotypes 
Also, rotavlruses In the clinical samples are rdentrfred and characterrzed 
extensively by comparlsun of the migration patterns of wraf genomtc RNAs by 
polyacryfamtde gel efectrophoresrs All Group A rdavlruses can be clawfied m k ,  
two distinct eiectropherutypes exh~b~ttry) etther 'long' or 'short' R M  pattern n 
which the mtgration of segment eleven IS fast ur slow, rsspectw1y M~r-ef, 
human rotavra1 strams with serotype 2 or 8 spcific~ty exhlM 'short' RNA 
slectropharotypas, M ~ l e  serwpe 1,3,4 and 9 stratns have 'long' RNA 
electropheratypes It has also been observed that the vast rnqonty of human 
rutawruses wth SGI spedictty have a 'short' RNA pattern where as those with 
SGll speafiaty have 'long' RNA pattern On the other hand, the great majonty of 
an~mal strams appear to have a 'long' RNA pattern but SGI spec~fic~ty Therefore, 
the occurrence of rotavlruses with 'long' RNA pattern and SGI speclfic~ty In 
humans IS an ~nd~catlon f the Irkellhood of the~r berng derlved from an~rnals In 
recent years several strarns of human rotavlrus have been rsolated that exh~b~t 
SGI specificity but 'long' RNA pattern These unusual strains exh~brt either a 
known or a new serotype spec~ficity and cause d~arrhoea in ch~ldren Some of 
these strains appear to be genet~cally related to rotavlrus stralns predominantly 
found in cats and dogs 
While rotavlrus ~nfection In young children below 5 years of age often 
causes severe diarrhoea, Infection In newborns IS often asymptomatic Earlier 
stud~es have indicated that neonatal human rotavlrus rnfect~ons may confer 
protection against subsequent development of d~arrhoea caused by symptomatic 
wruses Based on the hypothesis that neonatal strains represent naturally 
attenuateu vlruses, several invest~gators have proposed the neonatal strains as 
vaccine candidates The extensive morbtdity and mortality associated w~th 
rotawrus diarrhoea worldw~de, part~cularly In developing countries, has made the 
development of a rotavlrus vaccine a high priority programme 
The major objectives of this study were 
I To study the epidem~ology of asymptomatic and symptomat~c infect~ons in 
Bangalore and Mysore durtng a seven-yew period from 1988 to 1994 to 
understand the antigen~c nature (serotype) of lnd~an rotawr~ses~ 
il To characterize the gene encoding the SG-speaf~c antigen VP6 of the IS2 
(symptomat~c) stra~n and 1321 (asymptomat~c) strain of rotawrus to serve as 
nuclelc acid probes for detectfon of rotavrruses as wall as to deterrn~ne, 
genetic vanatton In VP6 from lnd~an stratns, 
r e  To express VP6 from the symptomatic stran IS2 m E CDIJ and production of 
antiserum against the expressed VP6 towards the goal of development of 
reagents for a recombinant vaccine In conjuction with VP4 and VP7 as well 
as to study the structure of VP6 
The results and conclus~ons are br~efiy summarlzed below 
1) Epi&mmbgy of asympiornak mnkimns 
A large number of samples were collected from healthy newborn ~nfants (2 
to 30 days old) from six general hospitals rn Bangalore and one general 
hosprtal In Mysore All the samples were analysed for thelr RNA mrgrat~on 
pattern (electropherotype), SG and serotype All the isolates exhlblted a 
'long' electropherotype and a SGI spec~frcity Strarns collected from hosp~tals 
separated by 5 to 10 km showed simllar characterist~cs These strains 
exhibited serotype 1 0 spectf~city Rotavlruses belongrng to serotype 1 0 are 
predominantly found only In cattle and have never been previously Identifled 
In healthy neonates Samples from Bangalore and Mysore showed srmrlar 
characteristics As they efficrently tnfect and replrcate in humans, grow well 
In cell culture and are naturally attenuated, I321 -hke asymptomatic strams 
represent the best candidates available so far for a 'Jennerian' type lrve 
rotavlrus vaccine either on thelr own or as reassortants 
2) Ep~demmlogy of symptomak mntbchons 
Stool samples were collected from young children between 3 months to 5 
years of age from 1988 to 1994 in Bangalore and 1993 to 1994 In Mysore 
These samples showed erther a 'long' or a 'short' pattern of migration A 
s~gn~ficant observation was that the lncldence of rotawrus mnfet31on In 
Bangalore was found to decrease from 45 3% In 1988 to 1 8% In 1994 Thrs 
IS In contrast to asymptomatrc ~nfect~ons whlch showed a frequency of about 
34% throughout the study perloci Thrs drast~c reductron in rotavlrus infectron 
over a per~od of ttme has not been reported anywhere The reason for tbrs 
reduction IS not clear It IS likely that this reduct~crn n the nurnbsr of 
gastroenter~tts case9 tn Bangalam is due to cfo235-protec%an effected by 
asymptomatrc infedons of neonates by 1321-ltke strains Whrfe m n s  
belongrng to SGil were found to be more predominant than those hawng SGI 
spsc~fictty, sewn strains wth dual SG spscrficity were also observed In 
Bangalore serotypes G2 and 63 were found to be predominant during 1988 
to 1 Q9a Serotypes 6 1  and G3 were more frequently observed dunng 1991 
and 19$2 uvhde serotype G2 and 6 4  were less frequent or absent Dur~ng the 
two-year study n Mysore, serotypes G1 and 63 were predom~nant wh~le 
serotype 62  and 64  were completely absent 
V~ruses with serotype 10 specific~ty were not detected In symptomatic 
infect~ons indicat~ng that the 1321 -hke asymptomatic strains are not involved 
In symptomatic infections Several stra~ns with SGI specificity and a 'short' 
pattern wh~ch did not show serotype 2 specificity were identified These 
strarns e~ther showed high reactiwt~es with all the serotype -specific 
monoclonal antibodies or showed very low react~vlt~es About 36% of the 
samples from Bangalore and 30% samples from Mysore could not be 
ass~gned any serotype Some of these strams may belong to uncommon 
serotypes l~ke G8 and G9 or represent stralns of unknown serotype 
specific~ty 
The results from these eptdemiolog~cal stud~es ~ndtcate that anttgen~calty 
distinct rotavlruses are arculat~ng In lnd~a and th~s fact should therefore be 
taken into account whrle des~gning vaccine strateg~es under the Indian 
context 
&rung and sequence analys~s of gene 6 k m  s p p t m a k  sirain 152 and 
aspptomatn: sban 1321 
Gene 6 encoding VP6 is the most consarved gene among group A 
rotavlruses from humans as well as an~mals and rs therefore a potemal 
candidate for use as a DNA probe for virus detection Also, because VP6 rs 
the most predom~nant prote~n [>SO%) of the virion, it 16 the antigen of choice 
for detect~on of rotawnrses by ELISA To date, there is no informatron an the 
extent of genetic and/or antigen~c varlat~on in gene 6 *om lnd~an ratmruses 
In thts study, gene 6 from the prototype symptomatic stram 182 and 
asymptornat~c stran 1321 were cloned and sequenced Both the genes were 
found to be 1356 bp In length and showed higher homology to bovlne 
rotaviruses rather than human rotavrruses These stud~es confirmed that 
gene 6 of 1321 IS also der~ved from the bovine vlrus Interesttngly, the 
symptornat~c IS2 stratn belonging to serotype 2 also contatned gene 6 that IS 
more dosely related to bovrne rotavirus ind~cat~ng that human serotype 2 
strams m~ght have armen due to reassortment between a bovtne and an yei 
unknown progenitor rotavlrus 
VP6 from IS2 straln showed substltut~on by lys~ne at two amino ac~d 
pos~t~ons 97 and 134 Ammo ac~ds at these two positions are h~ghly 
conserved In VP6 from all other group A rotav~ruses VP6 from IS2 straln IS 
consequently more bas~c than that from other group A rotavirus strarns 
Slnce VP4 from IS2 stra~n is more aad~c, due to acldrc amino acid 
substrtutions, than the VP4 alleles seen In other serotype 2 wruses, these 
complementary changes m~ght be essential for stablllzlng the lnteract~ons 
between these outer and intermed~ate shell protetns 
4 E k p r ~ n  of W6 from I S 2  stran of rotawrus 
VP6 from the IS2 strarn was expressed In E colt usrng the pET2Ob(+) 
expression vector The recombinant VP6 expressed from thls vector 
migrated as two distinct bands of 50 4 kDa and 48 0 kDa due to ~neffic~ent 
cleavage of the pels leader sequence Deletton of thrs leader sequence 
resulted In the express~on of a protetn of molecular weight 46 4 kDa Smaller 
protern products af 34 kDa, 24 kDa and 23 kDa were also detected which 
m~ght be cleavage products or may have arisen due to internal mltiatlon of 
translation wtth~n the gene 6 sequence 
The recamblnant VP6 was pwrrfied by angle-step affmrty chromatography 
and polydonal antiserum was rased aga~nst it in rabbrt Recambmatrt VP6 
was recognlzed by polyclonal amserum as welt as SGl-spectfic monoclonal 
ant~body that recogntres mformat~onal ep~tops ~ndrwittng that: VP6 
express@ in E wh has nave coprformatlon The productmn of r8comblnant 
VP6 consbtutes a part of the efforts directed towards understandrng the 
1 
structure of rotmrus ended proteins as well as dsvetopment of reagents 
for a comprehens~ve vaccine agarnst rc@wrus gastroenterrtrs under the 
